< Back to previous page
Researcher
Simon De Meyer
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Cardiovascular Sciences, Kulak Kortrijk Campus (Department)
Responsible
From1 Aug 2015 → Today - Cardiovascular Sciences, Kulak Kortrijk Campus (Department)
Member
From1 Jan 2013 → Today - Biomedical Sciences Group, Kulak Kortrijk Campus (Section)
Member
From1 Oct 2012 → 31 Dec 2012 - Chemistry, Kulak Kortrijk Campus (Department)
Member
From1 Oct 2010 → 30 Sep 2012 - Faculty of Science, Kulak Kortrijk Campus (Faculty)
Member
From1 Oct 2001 → 30 Sep 2010
Projects
1 - 10 of 43
- Universal Chimeric Antigen Receptor (UniCAR) T-cell therapy: an innovative treatment for autoimmune diseaseFrom5 Apr 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Universal chimeric antigen receptor (uniCAR)-T cell therapy to treat autoimmune diseases: immune mediated thrombotic thrombocytopenic purpura as a model system.From1 Mar 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Endothelium-targeted gene therapy for von Willebrand disease using a hybrid adeno-transposon strategyFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Flow cytometer for the Interdisciplinary Research Facility Life Sciences at Campus Kulak KortrijkFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Towards improved thrombolysis in acute ischemic strokeFrom1 Jan 2021 → 31 Oct 2021Funding: BOF - postdoctoral mandates
- Light sheet microscopy for interdisciplinary research in life sciencesFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Development and validation of a novel platform for fast and easy diagnosis of von Willebrand diseaseFrom1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
- Towards improved thrombolysis in ischemic stroke exploring novel therapeutic targetsFrom15 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development of a microfluidic platform for self-governing selection of individual B-cells using bioresponsive hydrogels: a source of fully human therapeutic antibodiesFrom20 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Thrombosis in COVID-19:dysregulation of the tromboinflammatory VWF/ADAMTS13 axis?From1 Apr 2020 → 31 Mar 2021Funding: IOF - technology validation in lab
Publications
11 - 20 of 141
- Basic science research opportunities in thrombosis and hemostasis: Communication from the SSC of the ISTH(2022)
Authors: Simon De Meyer
Pages: 1496 - 1506 - High Incidence of SARS-CoV-2 Variant of Concern Breakthrough Infections Despite Residual Humoral and Cellular Immunity Induced by BNT162b2 Vaccination in Healthcare Workers: A Long-Term Follow-Up Study in Belgium(2022)
Authors: Bas Calcoen, Winnie Kerstens, Maya Imbrechts, Thomas Vercruysse, Kai Dallmeier, Johan Van Weyenbergh, Piet Maes, Xavier Bossuyt, Hendrik Jan Thibaut, Karen Vanhoorelbeke, et al.
- Unusual Histopathological Findings in Mechanically Removed Stroke Thrombi - A Multicenter Experience(2022)
Authors: Sarah Vandelanotte, Simon De Meyer
- Thromboinflammation in Brain Ischemia: Recent Updates and Future Perspectives(2022)
Authors: Simon De Meyer
Pages: 1487 - 1499 - Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP(2021)
Authors: Laure De Waele, Claudia Tersteeg, Simon De Meyer, Karen Vanhoorelbeke
Pages: 4480 - 4484 - Studying Stroke Thrombus Composition After Thrombectomy What Can We Learn?(2021)
Authors: Senna Staessens, Simon De Meyer
Pages: 3718 - 3727 - Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura(2021)
Authors: Simon De Meyer, Karen Vanhoorelbeke
Pages: 3427 - 3435 - Determination of anti-ADAMTS-13 autoantibody titers in ELISA: Influence of ADAMTS-13 presentation and autoantibody detection(2021)
Authors: Charlotte Dekimpe, Kadri Kangro, Quintijn Bonnez, Claudia Tersteeg, Simon De Meyer, Karen Vanhoorelbeke
Pages: 2248 - 2255 - Mechanical Characterization of Thrombi Retrieved With Endovascular Thrombectomy in Patients With Acute Ischemic Stroke(2021)
Authors: Simon De Meyer
Pages: 2510 - 2517 - Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19(2021)
Authors: Senna Staessens, Simon De Meyer
Pages: 1760 - 1773
Patents
1 - 5 of 5
- Dual targeting of tafi and pai-1 (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)
- Compositions comprising adamts13 for use in methods for the recanalization of occluded blood vessels in an infarction (Inventor)
- Compositions comprising adamts13 for use in methods for the recanalization of occluded blood vessels in an infarction (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)